Europe « Science and Enterprise

Crispr Therapy Shown to Reduce Harmful Gut Microbes

By Alan, on May 31st, 2023%

A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects. . . . → Read More: Crispr Therapy Shown to Reduce Harmful Gut Microbes

AI-Designed Cancer Vaccine Shown to Act Against Melanoma

By Alan, on May 26th, 2023%

Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

By Alan, on May 24th, 2023%

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Rare Disease Search Adds Large Language Model A.I.

By Alan, on May 15th, 2023%

A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms. . . . → Read More: Rare Disease Search Adds Large Language Model A.I.

Quantum Technology Start-Up Accelerator Unveiled

By Alan, on May 11th, 2023%

A business incubator is underway to help start-up enterprises in Denmark working in quantum technologies, particularly with defense-related applications. . . . → Read More: Quantum Technology Start-Up Accelerator Unveiled

$15M Alternative Chicken, Fish Challenge Finalists Named

By Alan, on May 10th, 2023%

An international challenge competition seeking sustainable but realistic alternatives to natural chicken and fish protein named its six finalist teams. . . . → Read More: $15M Alternative Chicken, Fish Challenge Finalists Named

Crispr Therapy Shown to Remove E. Coli in Gut

By Alan, on May 5th, 2023%

New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics. . . . → Read More: Crispr Therapy Shown to Remove E. Coli in Gut

Venture Capital Group to Boost Climate Actions

By Alan, on April 25th, 2023%

A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions

Biotech Partners on Synthetic Proteins to Protect Crops

By Alan, on April 24th, 2023%

A developer of synthetic antibody-like proteins for protecting crops is collaborating with a global agricultural chemical company on sustainable biologic insect controls. . . . → Read More: Biotech Partners on Synthetic Proteins to Protect Crops

Biotech, Dairy Company Collaborate on Plant-Based Cheese

By Alan, on April 12th, 2023%

A maker of consumer dairy products and biotechnology food start-up are partnering on plant-based cheeses they say are indistinguishable from today’s dairy cheese. . . . → Read More: Biotech, Dairy Company Collaborate on Plant-Based Cheese

Subscribe for email alerts

Donate to Science & Enterprise

Like us on Facebook

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Specials

Guest Posts

Please share Science & Enterprise